Adverse pregnancy outcomes among HIV-positive pregnant women treated with efavirenz-containing antiretroviral drugs: a retrospective cohort study in the Cape Flats
Doctor Pharmaceuticae - Dpharm === The use of efavirenz (EFV) in the first trimester of pregnancy remains controversial. In South Africa, the use of EFV-containing antiretroviral therapy (ART) as part of a Fixed Dose Combination (FDC) during the first trimester of pregnancy started in April, 2013. L...
Main Author: | Mohammednur, Mohammedmekin Mohammedseid |
---|---|
Other Authors: | Mugabo, Pierre |
Language: | en |
Published: |
University of the Western Cape
2018
|
Subjects: | |
Online Access: | http://hdl.handle.net/11394/6185 |
Similar Items
-
Nevirapine- versus Efavirenz-based antiretroviral therapy regimens in antiretroviral-naive patients with HIV and Tuberculosis infections in India: a multi-centre study
by: Sanjeev Sinha, et al.
Published: (2017-12-01) -
Adsorption of antiretroviral drugs, efavirenz and nevirapine from aqueous solution by graphene wool: Kinetic, equilibrium, thermodynamic and computational studies
by: Adedapo O. Adeola, et al.
Published: (2021-12-01) -
Efavirenz challenge in patients with nevirapine induced Stevens-Johnson Syndrome
by: Thandekile C. Manzini, et al.
Published: (2016-12-01) -
Perbandingan Penggunaan Efavirenz dan Nevirapine Terhadap Kolesterol LDL Pasien HIV/AIDS
by: Anggriani Yusi, et al.
Published: (2019-08-01) -
Reconsidering first-line antiretroviral therapy in the pregnant population
by: Yoo, Sunny
Published: (2016)